Vivalto Santé
Status
Current
Country
France
Strategy
Partnership Fund
Sector
Entry
Nov-21
Fund
IK PF I
Website
News
Leading French group of private hospitals
Founded in 2009 by Daniel Caille and headquartered in Paris, France, Vivalto Santé (“the Group”) is a leading healthcare provider in Europe, focusing on medical, paramedical and surgical specialties, such as obstetrics, physiotherapy and radiotherapy.
At present, the Group has 25,000 employees, including 8,800 practitioners, who are based across its large and growing network of over 200 healthcare facilities in seven different countries. Vivalto Santé has a unique, shared governance model entitled ‘Third Way’ which enables practitioners to participate in strategic development choices nationally, regionally and institutionally.
IK Partners acquired a minority stake in Vivalto Santé in November 2021, alongside co-investors, the founder-backed investment fund 'Vivalto Partners', practitioners and management.
What Attracted Us to the Business
- Differentiated positioning and business model
- Outstanding integration track record
- Growing addressable market with robust long-term drivers
- Strong historical core in the West of France
Our Value Creation Strategy
We are working alongside management to:
- Continue organic growth and operational margin improvement;
- Further integrate recently acquired facilities into the organisation;
- Pursue further growth through strategic M&A; and
- Optimise portfolio value through real estate.
Quote from Vivalto Santé
“Our ambition goes beyond delivering high-quality care: it combines medical excellence with a deep understanding of what patients truly experience. We aim to redefine the patient journey by embedding their voice at the heart of every decision, building a more human and sustainable healthcare system. This is made possible through our Third Way model of shared governance, which brings physicians and management together to act as close as possible to patients’ needs. By aligning medical expertise with operational decisions, patient experience becomes a true driver of transformation.”
Emmanuel de Geuser, Group CEO
